Roche Holding AG (LTS:0QOK) Long-Term Debt: CHF25,222 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QOK Roche Holding AG LTS:0QOK
76 GF Score
Price CHF323.90
GF Value CHF241.34
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG Long-Term Debt?

Roche Holding AG LTS:0QOK 76 Long-Term Debt is CHF25,222 Mil as of Jun. 2026. GuruFocus rates LTS:0QOK with a GF Score™ of 76/100 and a GF Value™ of CHF241.34 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Roche Holding AG's Long-Term Debt for the quarter that ended in Jun. 2026 was CHF25,222 Mil.

Roche Holding AG's quarterly Long-Term Debt increased from Jun. 2025 (CHF26,464 Mil) to Dec. 2025 (CHF27,430 Mil) but then declined from Dec. 2025 (CHF27,430 Mil) to Jun. 2026 (CHF25,222 Mil).

Roche Holding AG's annual Long-Term Debt increased from Dec. 2023 (CHF24,810 Mil) to Dec. 2024 (CHF30,722 Mil) but then declined from Dec. 2024 (CHF30,722 Mil) to Dec. 2025 (CHF27,430 Mil).

Roche Holding AG  (LTS:0QOK) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Roche Holding AG Long-Term Debt Related Terms

Roche Holding AG Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Roche Holding AG's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roche Holding AG Long-Term Debt Chart

Roche Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16,076.00 21,391.00 24,810.00 30,722.00 27,430.00

Roche Holding AG Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28,420.00 30,722.00 26,464.00 27,430.00 25,222.00
LTS:0QOK
76GF Score
Roche Holding AG LTS:0QOK
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of CHF25,222 Mil mean?
Roche Holding AG (LTS:0QOK) has a Long-Term Debt of CHF25,222 Mil as of Jun. 2026.
Is Roche Holding AG's Long-Term Debt too high?
Roche Holding AG's current Long-Term Debt is CHF25,222 Mil. Overall, Roche Holding AG has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Roche Holding AG's Long-Term Debt compare to LLY and JNJ?
Roche Holding AG's Long-Term Debt of CHF25,222 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Roche Holding AG's current Long-Term Debt is CHF25,222 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roche Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Roche Holding AG (LTS:0QOK) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF241.34, compared to a current price of CHF323.90 — trading 34.2% above its estimated fair value. The current Long-Term Debt is CHF25,222 Mil. Roche Holding AG's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Roche Holding AG (LTS:0QOK), the current Long-Term Debt is CHF25,222 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Roche Holding AG (LTS:0QOK) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of CHF323.90 is trading 34.2% above its estimated GF Value™ of CHF241.34. GuruFocus considers Roche Holding AG to be Significantly Overvalued.

Key valuation signals for LTS:0QOK:

  • Long-Term Debt: CHF25,222 Mil
  • GF Value™: CHF241.34 vs. price of CHF323.90 (34.2% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the LTS:0QOK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
76GF Score

Get the complete analysis for LTS:0QOK

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF323.90
Price
CHF241.34
GF Value